Company / Capital Expenditures
Erasca, Inc. Capital Expenditures History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$60.0K
FY2024
5-year range
$60.0K / $14.6M
FY2020-FY2024
Trend
-96.6%
vs FY2023
Sector context
#173 of 194
Health Care
What the data says
Erasca, Inc.'s capital expenditures of $60,000 is lower than 89% of companies in the Health Care sector (FY2024). Declined from $15M to $60,000 over the past 2 years.
Based on SEC 10-K filings.
$60,000 in FY2024 with a 3-year CAGR of -82.5%.
Declined from $15M to $60,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -82.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 194This company $60.0K Sector average $117.5M
▼
-99.9% below sector average
Key checks
Key Insights
- 3-year CAGR of -82.5%, indicating a declining trend.
- In FY2024, capital expenditures decreased 96.6% year-over-year.
- Ranks #173 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $60.0K | -96.6% |
| FY2023 | $1.8M | -87.8% |
| FY2022 | $14.6M | +29.9% |
| FY2021 | $11.2M | +1083.2% |
| FY2020 | $947.0K | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026